In the specific case of TMPRSS2-ERG, the androgen sensitivity of the TMPRSS2 promoter is responsible for the steroid-dependent expression of oncogene ERG in prostate epithelium, a key event in prostate carcinogenesis. Here, ERG is linked to urogenital neoplasm.